Dear Colleagues,
Welcome to the September issue of Science Speaks!
In this month's issue you can find our recently published article about today's Russian clinical trial environment.
If you missed the previous issue of Science Speaks!, take a look at our article that is addressing issues affecting clinical trials in Brazil.
Furthermore, we would like to inform you about recent Biotech News, a new category we added to our Science Speaks! Newsletter.
Please visit our website at www.languageconnections.com to learn more about our services and publications.
Enjoy!
|
Today's Russian Clinical Trial Environment
|
 We have recently published an article in the International Journal of Clinical Practice entitled "Today's Russian Clinical Trails" that will be available in the September 2010 issue, Volume 64, Issue 10; pp.1347-1349. (Online for members since August 2010, Members, Read Now)Over the past five years there has been exponential growth of clinical research
outsourced to Russia - the number
of Russian trials reportedly doubled between 2000 and 2006, while the number of
patients participating in global clinical trials in Russia more than tripled during the
same period. Read more... |
Addressing issues affecting clinical trials in Brazil
|
In case you missed last month's newsletter, we have published an article in the June 2010 issue of Informa Healthcare Clinical
Research entitled "Addressing Issues Affecting
Clinical Trials in Brazil." 
This article discusses how Brazil is quickly becoming a
dominant outsourcing location for clinical trials. Factors include an improved
regulatory environment, a large and ethnically diverse patient population, as
well as reduced costs and higher patient recruitment relative to more developed
Western countries. |
Biotech News: Text Messaging to track anti-malarial drugs in Africa
|
 The Associated Press recently reported on a new effort to
use text messages to track the authenticity of anti-malarial drugs in Africa where more than 30 % of malaria drugs are
estimated to be counterfeit. With this new texting system, known as mPedigree, a
unique code is assigned to all genuine malarial medicines. Consumers simply
send a text of this code to a 'central hotline' to verify whether the drug has been
properly registered.
Read more...
|
